File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Race, medicine, and social justice: Pharmacogenetics, diversity, and the case of BiDil

TitleRace, medicine, and social justice: Pharmacogenetics, diversity, and the case of BiDil
Authors
KeywordsHealth policy
Pharmacogenetics
Racial disparities
Social justice
Issue Date2008
PublisherBlackwell Publishing, Inc. The Journal's web site is located at http://www.blackwellpublishing.com/journal.asp?ref=1541-132X
Citation
Review Of Policy Research, 2008, v. 25 n. 1, p. 53-69 How to Cite?
AbstractIn this article, I probe an example of high-technology medicine as a case study in the problems of the regulation of advancing technology. Specifically, I address the implications of pharmacogenomics-an emerging form of population-based health care intervention-for public policies designed to eliminate racial disparities in health. Using the case of BiDil, a historical precursor to pharmacogenetic technology, I offer a framework for further studies of high-technology medicine in which policy analysis is part of a social review based on the justice standard of ex ante mutual advantage. It is the contention in this article that the most just and reasonable deployment of pharmacogenomics is as a compensatory tool to alleviate health disparities. © 2008 by The Policy Studies Organization.
Persistent Identifierhttp://hdl.handle.net/10722/81426
ISSN
2015 Impact Factor: 1.167
2015 SCImago Journal Rankings: 1.058
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorJordan, SRen_HK
dc.date.accessioned2010-09-06T08:17:33Z-
dc.date.available2010-09-06T08:17:33Z-
dc.date.issued2008en_HK
dc.identifier.citationReview Of Policy Research, 2008, v. 25 n. 1, p. 53-69en_HK
dc.identifier.issn1541-132Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/81426-
dc.description.abstractIn this article, I probe an example of high-technology medicine as a case study in the problems of the regulation of advancing technology. Specifically, I address the implications of pharmacogenomics-an emerging form of population-based health care intervention-for public policies designed to eliminate racial disparities in health. Using the case of BiDil, a historical precursor to pharmacogenetic technology, I offer a framework for further studies of high-technology medicine in which policy analysis is part of a social review based on the justice standard of ex ante mutual advantage. It is the contention in this article that the most just and reasonable deployment of pharmacogenomics is as a compensatory tool to alleviate health disparities. © 2008 by The Policy Studies Organization.en_HK
dc.languageengen_HK
dc.publisherBlackwell Publishing, Inc. The Journal's web site is located at http://www.blackwellpublishing.com/journal.asp?ref=1541-132Xen_HK
dc.relation.ispartofReview of Policy Researchen_HK
dc.subjectHealth policyen_HK
dc.subjectPharmacogeneticsen_HK
dc.subjectRacial disparitiesen_HK
dc.subjectSocial justiceen_HK
dc.titleRace, medicine, and social justice: Pharmacogenetics, diversity, and the case of BiDilen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1541-132X&volume=25&spage=53&epage=69&date=2008&atitle=Race,+Medicine,+and+Social+Justice:+Pharmacogenetics,+Diversity+and+the+Case+of+BiDilen_HK
dc.identifier.emailJordan, SR: sjordan@hku.hken_HK
dc.identifier.authorityJordan, SR=rp00551en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/j.1541-1338.2008.00309.xen_HK
dc.identifier.scopuseid_2-s2.0-38649093922en_HK
dc.identifier.hkuros146722en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-38649093922&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume25en_HK
dc.identifier.issue1en_HK
dc.identifier.spage53en_HK
dc.identifier.epage69en_HK
dc.identifier.eissn1541-1338-
dc.identifier.isiWOS:000207669300005-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridJordan, SR=23479888000en_HK
dc.identifier.citeulike2311995-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats